IGALMI
Bioxcel Therapeutics, Inc.
Mark For: IGALMI® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90295383 |
| Registration Number | 1595905 |
| Mark Literal Elements | IGALMI |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | INTENT TO USE SECTION 2021-12-28 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Brendan J. Hughes |
| Attorney Docket Number | 332712-20000 |
Timeline
| 2020-11-03 | Application Filed |
| 2020-11-06 | Location: NEW APPLICATION PROCESSING |
| 2020-11-06 | Status: Live/Pending |
| 2020-11-07 | Transaction Date |
| 2021-05-18 | Published |
| 2021-12-28 | Location: INTENT TO USE SECTION |
| 2023-06-12 | Status: A third request for extension of time to file a Statement of Use has been granted. |
Trademark Parties (Applicants & Owners)
| Party: |  Bioxcel Therapeutics, Inc. |
| Address | 555 Long Wharf Drive, 12th Floor New Haven, CONNECTICUT UNITED STATES 06516 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Application | 2020-11-03 | |
| Drawing | 2020-11-03 | |
| XSearch Search Summary | 2021-04-08 | |
| TRAM Snapshot of App at Pub for Oppostn | 2021-04-10 | |
| Notice of Publication | 2021-04-28 | |
| Notification Of Notice of Publication | 2021-04-28 | |
| OG Publication Confirmation | 2021-05-18 | |
| TTAB Order | 2021-11-04 | |
| Notice of Allowance | 2021-12-28 | |
| Extension of Time to File SOU | 2022-05-31 | |
| ITU Extension Approval | 2022-06-02 | |
| ITU Unit Action | 2022-06-02 | |
| Extension of Time to File SOU | 2022-12-06 | |
| ITU Extension Approval | 2022-12-08 | |
| ITU Unit Action | 2022-12-08 | |
| Extension of Time to File SOU | 2023-06-12 | |
| ITU Extension Approval | 2023-06-14 | |
| ITU Unit Action | 2023-06-14 |
Attorney of Record
Good, Services, and Codes
IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceuticals for the treatment of agitation; pharmaceuticals for the treatment of agitation associated with neuropsychiatric conditions, neurodegenerative diseases, alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, or other central nervous system disorders
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceuticals for the treatment of agitation; pharmaceuticals for the treatment of agitation associated with neuropsychiatric conditions, neurodegenerative diseases, alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, or other central nervous system disorders |
Assignments
| Description | Date |
|---|---|
 Trademark Assignment 7696-0356 [17 Pages] | 2022-04-19 |
| Trademark Assignment 7696-0476 [7 Pages] | 2022-04-19 |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-06-14 | |
| SOU TEAS EXTENSION RECEIVED | 2023-06-12 | |
| SOU EXTENSION 3 GRANTED | 2023-06-12 | 98765 |
| SOU EXTENSION 3 FILED | 2023-06-12 | 98765 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-12-08 | |
| SOU TEAS EXTENSION RECEIVED | 2022-12-06 | |
| SOU EXTENSION 2 GRANTED | 2022-12-06 | 98765 |
| SOU EXTENSION 2 FILED | 2022-12-06 | 98765 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-06-02 | |
| SOU TEAS EXTENSION RECEIVED | 2022-05-31 | |
| SOU EXTENSION 1 GRANTED | 2022-05-31 | 98765 |
| SOU EXTENSION 1 FILED | 2022-05-31 | 98765 |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2021-12-28 | |
| TTAB RELEASE CASE TO TRADEMARKS | 2021-11-15 | 271682 |
| OPPOSITION TERMINATED NO. 999999 | 2021-11-15 | 271682 |
| OPPOSITION DISMISSED NO. 999999 | 2021-11-15 | 271682 |
| OPPOSITION INSTITUTED NO. 999999 | 2021-09-15 | 271682 |
| EXTENSION OF TIME TO OPPOSE RECEIVED | 2021-06-15 | |
| PUBLISHED FOR OPPOSITION | 2021-05-18 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-05-18 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-04-28 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-04-09 | |
| ASSIGNED TO EXAMINER | 2021-04-08 | 85324 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-12-31 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2020-12-31 | |
| NEW APPLICATION ENTERED IN TRAM | 2020-11-06 | |
| NEW APPLICATION ENTERED | 2020-11-06 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 IGALMI 98620766 not registered Live/Pending |
BioXcel Therapeutics, Inc. 2024-06-26 |
 IGALMI 90295383 not registered Live/Pending |
Bioxcel Therapeutics, Inc. 2020-11-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 